PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12145914

[IMCO(++)--a Monte Carlo based IMRT system].

Matthias Hartmann·Ludwig Bogner·Matthias Fippel·Josef Scherer·Stefan Scherer
View original source ↗Export metadata ↓

Abstract

The application of intensity modulated radiotherapy (IMRT) to dose escalation in the target volume sets particular demands in terms of accuracy of dose calculation. Dose calculation errors due to approximations are compensated by the optimization algorithm, a procedure that ultimately leads to incorrect fluence modulation. Such inaccuracies affect particularly the dose distribution in areas with secondary electron disequilibrium. In case tissues heterogeneity predominates, conventional dose calculation methods (such as Pencil Beam) can produce relative errors up to more than 10%. The accuracy can be significantly improved by the application of a Monte-Carlo (MC) algorithm. This paper describes a MC-based inverse treatment planning algorithm (IMCO++), based on a non-iterative approach with a feedback-controlling process. The convergence behavior of IMCO++ was investigated and the used MC dose-calculation codes MMms and XVMC were compared by means of a heterogeneous phantom. IMCO++ plans were optimized in various phantoms. All plans showed conformity in terms of dose distribution of the target volume and dose reduction in risk organs (according to the requirements of the target parameter), as well as a very fast convergence of the algorithm (in less than 10 optimization steps).

Explore related subjects

HumansMonte Carlo MethodPhantoms, ImagingRadiotherapy DosageRadiotherapy Planning, Computer-AssistedEnglish AbstractJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Matthias Hartmann, Ludwig Bogner, Matthias Fippel, Josef Scherer, Stefan Scherer. 2002. [IMCO(++)--a Monte Carlo based IMRT system].. https://doi.org/10.1016/s0939-3889(15)70452-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗